Trends in the antibiotic resistance patterns of enteric fever isolates - A three year report from a tertiary care centre

Malaysian Journal of Medical Sciences

Volumn 20, Issue 4, 2013, Pages 70-74

  Gupta, Varsha ^a   Singla, Nidhi ^a   Bansal, Neha ^a   Kaistha, Neelam ^a   Chander, Jagdish ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Antibiotic resistance; Ceftriaxone; Ciprofloxacin; Enteric fever; Salmonella

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID;

AGAR DILUTION; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SPECIES DIFFERENCE; TERTIARY HEALTH CARE; TREND STUDY; TYPHOID FEVER;

EID: 84881221597     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Harish BN, Menezes GA. Antimicrobial resistance in typhoidal salmonellae. Indian J Med Microbiol. 2011;29(3):223-239.
2. Cooke FJ, Wain J. The emergence of antibiotic resistance in typhoid fever. Travel Med Infect Dis. 2004;2(2):67-74.
3. Lakshmi V, Ashok R, Susmita J, Shailaja W. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol. 2006;24(1):45-48.
4. Gupta V, Kaur J, Kaistha N. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India. Trop Doct. 2009;39(1):28-30.
5. Bauer AW, KirbyWMM, Sherris JC, TurckM. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493-496.
6. CLSI. Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100-S19. Wayne (PA): Clinical and Laboratory Standards Institute 2009.
7. Manchanda V, Bhalla P, Sethi M, Sharma PK. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and Paratyphi A. Indian J Med Microbiol. 2006;24(2):101-106.
8. Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol. 2008;57(10):1247-1250.
9. Chowta MN, Chowta NK. Study of clinical profile and antibiotic response in typhoid fever. Indian J Med Microbiol. 2005;23(2):125-127.
10. Nagshetty K, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries. 2010;4(2):70-73.
11. Harish BN, Menezes GA. Preserving efficacy of chloramphenicol against typhoid fever in a tertiary care hospital, India. Regional Health Forum, WHO South-East Asia Region. 2011;15(1):92-96.
12. Indian Network for Surveillance of Antimicrobial Resistance Group. Antibiogram of S. enterica serovar Typhi and S. enterica serovar Paratyphi A: a multicentre study from India. WHO South-East Asia Journal of Public Health. 2012;1(2):182-188.
13. Saha S., Talukder SY, Islam M, Saha S. A highly ceftriaxone resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J. 1999;18(4):387.
14. Capoor MR, Nair D, Hasan AS, Aggarwal P, Gupta B. Narrowing therapeutic options in typhoid fever, India. Southeast Asian J Trop Med Public Health. 2006;37(6):1170-1174.
15. Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of highlevel ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol. 2007;56(8):1131- 1132.
16. Gokul BN, Menezes GA, Harish BN. ACC-1 betaLactamase-producing Salmonella enterica serovar Typhi, India. Emerg Infect Dis. 2010;16(7):1170- 1171.
17. Pokhare BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL) producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: Surveillance of resistance and a search for newer alternatives. Int J Infect Dis. 2006;10(6):434-438.
18. Rotimi VO, Jamal W, Pal T, Sovenned A, Albert MJ. Emergence of CTX-M-15 type extended-spectrum â-lactamaseproducing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol. 2008;57(7):881-886.
19. Al Naiemi N, Zwart B, Rijnsburger MC, Roosendaal R, Debets-Ossenkopp YJ, Mulder JA, et al. Extendedspectrum-beta lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol. 2008;46(8):2794-2795.
20. Sen B, Bhattacharya M, Niyogi SK. In vitro activity of cefpodoxime an expanded spectrum cephalosporin against Salmonella enterica serotype Typhi. Antimicrob Agents Chemother. 2008;52(2):802- 803.